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OBJECTIVE—To evaluate temporal trends in rates of initial lower extremity amputation
(ILEA) among patients with diabetes in the Veterans Health Administration (VHA).
RESEARCH DESIGN AND METHODS—Retrospective administrative data analysis of
VHA clinic users with diabetes in ﬁscal years (FY) 2000 to 2004 (1 October 1999–30 September
2004). We calculated annual age– and sex–standardized rates of initial major, minor, and total
amputations for the overall population and for various racial/ethnic groups (African Americans,
Hispanics, and whites). Trends in ILEA risk were evaluated with and without adjustment for
demographiccharacteristicsandotherpotentialriskfactors,includingpresenceofmicrovascular
and macrovascular diseases, and antiglycemic treatment.
RESULTS—Study populations of VHA patients with diabetes and without prior amputations
ranged from 405,580 in FY 2000 to 739,377 in FY 2004. Age- and sex-standardized ILEA rates
decreasedby34%(7.08/1,000patientsinFY2000to4.65/1,000patientsinFY2005)duringthe
5-year period. Minor and major amputation rates decreased by 33% (4.59 to 3.06/1,000) and
36% (2.49 to 1.59/1,000), respectively. Of major amputations, below-knee ratesdecreased from
1.08 to 0.87/1,000 (219%), and above-knee decreased from 1.41 to 0.72/1,000 (249%). Sim-
ilar trends were seen for all racial groups. ILEA risk decreased by 28% (odds ratio 0.72 [95% CI
0.68–0.75])whenFY2004wascomparedwithFY2000inthemodel,adjustingfordemographic
characteristics. This risk decrease was 22% in the model adjusting for all independent variables
(odds ratio 0.78 [95% CI 0.74–0.82]).
CONCLUSIONS—Downward 5-year trends in ILEA rates were observed for all amputation
levels and among all racial groups, even after adjustment for risk differences over time.
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L
ower extremity amputations (LEAs)
are a catastrophic complication of
diabetes, often leading to loss of
ambulatory status, permanent disability,
andhighoperativemortality(1).LEAsare
considered to be a prevention quality in-
dicator, that is, a condition for which on-
set or hospital admission is potentially
preventable by timely and effective
ambulatory care (2). Reducing the rate
of LEAs was a major objective of Healthy
People2010(3).SeveralrecentU.S. stud-
ies have reported population trends in
LEA rates. Among Medicare fee-for-service
beneﬁciaries, rates fell by 26% from 1992
to 2001 (4), and amputation rates de-
creased by 37% from 1998 to 2004 in the
U.S. population with diabetes (5).
Interpretationoftheclinicalandpolicy
signiﬁcance of these ﬁndings is tempered,
however, by methodologic limitations of
t h es t u d i e s .F i r s t ,t h eﬁndings of “de-
creased” amputation rates could be partly
attributed to a “denominator” effect. The
incidence of LEAs is extremely uncom-
mon in the ﬁrst 10 years after diagnosis,
even when a fasting blood glucose ,140
mg/dL was used as the basis for diagnosis
(6). There have been secular trends in di-
agnostic criteria and screening intensity
for diabetes (7); for example, diabetes is
diagnosed earlier as a result of a 1997
change by the American Diabetes Associ-
ation in the fasting blood glucose level
from 140 to 126 mg/dL.
As a consequence, there may have
been more patients with diabetes of more
recent onset in the later years of these
studies. Because these patients would
increase the number in the denominators
but not be expected to increase the num-
ber of lower extremity amputations over
a short period of time, they would tend
to bias LEA rates downward. Therefore,
when trends of amputations over time
are evaluated, it is necessary to adjust for
possible differences in risk factors of am-
putations in the denominators (or study
populations) over time.
Furthermore, reliance on total ampu-
tations (2–5) as the only outcome in eval-
uating access to and quality of foot care
maynot beappropriate for several reasons:
ﬁrst,thefunctionaloutcomesofminorand
major amputations differ markedly (8).
Second, an increased emphasis on foot
care and surveillance programs could lead
to earlier recognition of limb-threatening
conditions that could increase rates of mi-
nor amputations while decreasing rates of
major amputations (9). Thus, the ratio of
major/minor amputations (10), as well as
simultaneous evaluation of major and mi-
nor amputations (11), have been proposed
to evaluate quality of foot care. In contrast
to U.S. Federal Agencies (2,3), the Organi-
zation for Economic Collaboration and
Development Health Indicators Project
recommended that reporting of LEA rates
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ORIGINAL ARTICLEshould be conﬁned to major amputations
(12). Finally, because repeat amputations
would represent a failure of multidisci-
plinary salvage programs, evaluation of
initial amputations may better reﬂect
the effectiveness of primary prevention
through surveillance (13).
The Veterans Health Administration
(VHA) is the largest integrated health care
system in the U.S. and has a national
electronic health care record and data
warehousethatstoresthemedicalrecords
of each patient. The VHA and some re-
gional health plans both provide more
complete patient information compared
with Medicare data as a result of the
availability of linked pharmacy, labo-
ratory, and claims data. However, the
VHA offers a different perspective in
population-based outcomes research
compared with the regional health plans,
because it is a national system that func-
t i o n sa sa“safety net,” in that access is
based on entitlement without consider-
ation of pre-existing conditions (14). We
have previously used combined patient-
level VHA and Medicare databases to
develop risk prediction models for total
(15) and minor and major amputations
(11) and evaluated rates of initial versus
repeat amputations (16). The objective of
this study was to evaluate risk-adjusted
trendsininitialminor,major,andtotalam-
putations among veterans in ﬁscal years
(FYs) 2000–2004 and to determine
whether trends in rates varied across ra-
cial and ethnic groups.
RESEARCH DESIGN AND
METHODS
Study population
For this serial cross-sectional study, we
used the Diabetes Epidemiology Cohorts
data, a database of all VHA patients with
diabetes since 1998 containing linked
longitudinal patient records derived
from inpatient and outpatient services
in the VHA or in the private sector and
covered by Medicare (17). Diabetes was
determined using a previously validated
approach based on prescriptions for dia-
betes medication in the current year or
having 2 or more days with diabetes-
speciﬁc International Classiﬁcation of
Diseases–Clinical Modiﬁcation, 9th edi-
tion (ICD-9-CM) codes (250.xx, 357.2,
362.0, 366.41) from inpatient stays or
outpatient physician visits during the
prior 2 years. For each year in FYs
2000–2004, we identiﬁed patients with
diabetes who were alive at the beginning
of the year and had no prior amputation
in the previous 24 months. Patients en-
rolledinMedicareHealthMaintenanceOr-
ganizationplansintheprevious24months
(,3%) were excluded because their health
information was not available.
Outcome measures
First, we removed individuals from the
numerator and denominator who had
evidence of any prior amputation. These
included the presence of ICD-9-CM pro-
cedure codes for any LEA (84.13)a sw e l l
as post-amputation codes and lower limb
prosthetic codes (997.60, 997.61, 997.62,
997.69, V497.3,V 5 2 1 . 3)i na n yﬁeld in
either VHA or Medicare inpatient records,
as described previously (16).
Second, we deﬁned our study out-
comes, an initial LEA (ILEA) hospitaliza-
tion,asonewiththepresenceofICD-9-CM
procedure codes for any LEA (84.13). Mi-
nor amputations were deﬁned as toe
(84.11), transmetatarsal (84.12–84.13),
and distal transtibial (including Symes,
84.14) amputations. Major amputations
were deﬁned as transtibial (below-knee,
84.15, 84.16) and transfemoral (above-
knee, 84.17–84.19). Multiple procedures
with the same ICD-9-CM code on the
same day were considered to be a single
amputation because there are no modiﬁers
toenableidentiﬁcationofbilateralamputa-
tions. Different amputation codes during
the same hospitalization were assigned
as a single procedure at the highest ana-
tomic level.
Independent variables
Demographic variables included age
(,55, 55–64, 65–74, and $75 years),
sex,race/ethnicity(white,AfricanAmerican,
Hispanic, other [e.g., Asian American,
Native American, etc.], and unknown),
marital status (married, other, and un-
known), census regions (Northeast, Mid-
west, South, West, and unknown), and
census rural/urban continuum (0 = ex-
tremely urban to 9 = extremely rural). Us-
ing the veterans’ VHA enrollment priority
status, which determines payment status
and eligibility for services in the VHA
based on their status of military-connected
disability and income, patients were
characterized as severely disabled, mod-
erately disabled, poor, co-pay required,
and unknown.
Variables reﬂecting health status in-
cludedmacrovascular(coronaryarterydis-
ease, congestive heart failure, arrhythmia,
stroke,andperipheralvasculardisease),mi-
crovascular(chronicrenalpathophysiology,
diabetic nephropathy, acute renal failure,
end-stage renal disease, dialysis, diabetic
retinopathy, and ulcer), and metabolic
complications (uncontrolled diabetes and
short-term complication of diabetes). The
ICD-9-CM diagnoses codes were used to
determine the presence of these medical
conditions. Neuropathy was not included
because our prior work indicated that it
was so poorly coded (~2%) as to be
unreliable (15).
Finally, diabetes medications (no
medications or oral medications only,
oralmedications with insulin,andinsulin
only) were included as a proxy for the
duration of type 2 diabetes, recognizing
thatindividualswithtype1diabeteswould
be included in the insulin-only category.
The independent variables were ascer-
tained for each year of comparison; the
information from the previous years was
used for missing values. All missing data
were treated as a separate category in each
variable for the statistical analysis except
for sex. Patients without sex information
(0.01–0.02%) were removed from the sta-
tistical analysis.
Statistical techniques
First, to help evaluate the changes in
population characteristics across years of
comparisons, we obtained the frequen-
cies and percentages of subcategories in
theindependentvariablesasdescribedfor
each year of comparison (Table 1). Sec-
ond, we evaluated ILEAs across the 5
years of study. For each of the 5 years,
we obtained counts of the denominator,
major (above- and below-knee), and mi-
nor amputations. We then calculated an-
nual crude rates of ILEAs and rates
directly standardized to the age and sex
composition of our study population in
FY 2000 (18). ILEA rates were also com-
puted separately for initial minor and ma-
jor (below- and above-knee) amputations
and for various racial/ethnic groups (His-
panics, African Americans, and whites).
The statistics for age- and sex-standardized
rates are presented in Table 2.
To compare ILEA rates over the 5
years, we used logistic regression models,
combined data across the years, and in-
cluded year as an independent categoric
variable. The year variable was also treated
as a continuous measure to evaluate the
robustness of the ﬁndings. We report odds
ratios (ORs) and 95% CIs. Independent
variableswereaddedtothemodelstohelp
adjust for population differences over the
years of comparisons based on a previ-
ously validated model (15). In building
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Amputation rates in the Veterans AdministrationTable 1—Proﬁles of population with diabetes and no prior amputations in the VHA: FY 2000–2004
Variable FY 2000 FY 2001 FY 2002 FY 2003 FY 2004
Denominator 405,580 454,221 514,970 651,752 739,377
Age category
18–44 years 13,606 (3.36) 14,105 (3.11) 14,432 (2.80) 14,669 (2.25) 15,130 (2.05)
45–54 years 65,104 (16.05) 72,458 (15.96) 74,513 (14.47) 75,974 (11.66) 76,193 (10.31)
55–64 years 74,267 (18.31) 88,013 (19.38) 110,286 (21.42) 139,722 (21.44) 176,809 (23.91)
65–74 years 135,093 (33.31) 143,998 (31.71) 159,533 (30.98) 203,212 (31.18) 223,817 (30.27)
75–84 years 108,735 (26.81) 124,455 (27.41) 141,809 (27.54) 194,707 (29.88) 216,104 (29.23)
$85 years 8,714 (2.15) 11,082 (2.44) 14,315 (2.78) 23,358 (3.58) 31,278 (4.23)
Missing 61 (0.02) 110 (0.02) 82 (0.02) 110 (0.02) 46 (0.01)
Sex
Female 10,484 (2.58) 12,101 (2.66) 13,893 (2.70) 16,977 (2.60) 19,348 (2.62)
Male 395,035 (97.40) 442,010 (97.31) 500,995 (97.29) 634,715 (97.39) 719,983 (97.38)
Missing 61 (0.02) 110 (0.02) 82 (0.02) 60 (0.01) 46 (0.01)
Race/ethnicity
African American 73,320 (18.08) 80,290 (17.68) 87,553 (17.00) 97,417 (14.95) 104,530 (14.14)
Hispanic 13,077 (3.22) 14,853 (3.27) 16,282 (3.16) 18,381 (2.82) 20,025 (2.71)
Other 7,702 (1.90) 8,571 (1.89) 9,602 (1.86) 11,254 (1.73) 12,390 (1.68)
White 302,086 (74.48) 337,414 (74.28) 383,164 (74.41) 498,024 (76.41) 560,365 (75.79)
Missing 9,395 (2.32) 13,093 (2.88) 18,369 (3.57) 26,676 (4.09) 42,067 (5.69)
Marital status
Married 242,060 (59.68) 273,994 (60.32) 316,160 (61.39) 419,032 (64.29) 482,832 (65.30)
Not married 160,643 (39.61) 177,092 (38.99) 195,837 (38.03) 228,862 (35.11) 252,135 (34.10)
Missing 2,877 (0.71) 3,135 (0.69) 2,973 (0.58) 3,858 (0.59) 4,410 (0.60)
Census region
Northeast 67,120 (16.55) 74,025 (16.30) 83,462 (16.21) 104,967 (16.11) 118,459 (16.02)
Midwest 89,922 (22.17) 98,497 (21.68) 112,518 (21.85) 147,419 (22.62) 167,421 (22.64)
South 172,623 (42.56) 195,461 (43.03) 222,063 (43.12) 281,547 (43.20) 321,683 (43.51)
West 60,431 (14.90) 68,259 (15.03) 77,707 (15.09) 95,894 (14.71) 108,261 (14.64)
Missing 15,484 (3.82) 17,979 (3.96) 19,220 (3.73) 21,925 (3.36) 23,553 (3.19)
Rural-urban continuum
Metro extremely urban 116,308 (28.68) 128,694 (28.33) 143,906 (27.94) 177,675 (27.26) 201,173 (27.21)
Metro 1 12,495 (3.08) 14,195 (3.13) 16,496 (3.20) 21,615 (3.32) 24,916 (3.37)
Metro 2 100,866 (24.87) 112,940 (24.86) 128,529 (24.96) 164,021 (25.17) 184,121 (24.90)
Nonmetro 3 40,852 (10.07) 46,316 (10.20) 53,102 (10.31) 70,187 (10.77) 79,100 (10.70)
Nonmetro 4 19,065 (4.70) 21,531 (4.74) 24,595 (4.78) 32,413 (4.97) 36,589 (4.95)
Nonmetro 5 14,706 (3.63) 16,581 (3.65) 19,013 (3.69) 24,735 (3.80) 27,399 (3.71)
Nonmetro 6 38,452 (9.48) 43,171 (9.50) 49,245 (9.56) 62,402 (9.57) 69,303 (9.37)
Nonmetro 7 32,944 (8.12) 36,751 (8.09) 41,669 (8.09) 53,879 (8.27) 59,873 (8.10)
Nonmetro 8 6,678 (1.65) 7,405 (1.63) 8,364 (1.62) 10,548 (1.62) 11,636 (1.57)
Extremely rural 9,684 (2.39) 10,899 (2.40) 12,396 (2.41) 16,338 (2.51) 18,175 (2.46)
Missing 13,530 (3.34) 15,738 (3.46) 17,655 (3.43) 17,939 (2.75) 27,092 (3.66)
Veterans priority status
1–SC disability, 50% 76,993 (18.98) 87,608 (19.29) 104,712 (20.33) 129,438 (19.86) 149,988 (20.29)
2–SC disability, 30–40% 33,301 (8.21) 36,401 (8.01) 39,738 (7.72) 45,466 (6.98) 49,836 (6.74)
3–Other disability, POW 49,153 (12.12) 56,513 (12.44) 58,623 (11.38) 69,961 (10.73) 76,692 (10.37)
4–Catastrophic disability 32,184 (7.94) 35,674 (7.85) 37,169 (7.22) 40,910 (6.28) 43,784 (5.92)
5–Poverty 168,976 (41.66) 186,151 (40.98) 201,741 (39.18) 234,043 (35.91) 251,933 (34.07)
6–Other 3,933 (0.97) 3,343 (0.74) 3,033 (0.59) 3,518 (0.54) 3,861 (0.52)
7–Copay 35,085 (8.65) 44,411 (9.78) 65,464 (12.71) 125,425 (19.24) 159,964 (21.63)
Missing 5,955 (1.47) 4,120 (0.91) 4,490 (0.87) 2,991 (0.46) 3,319 (0.45)
Microvascular disease 158,899 (39.18) 177,162 (39.00) 201,768 (39.18) 250,383 (38.42) 279,424 (37.79)
Macrovascular disease 219,054 (54.01) 241,533 (53.18) 272,795 (52.97) 355,926 (54.61) 400,559 (54.18)
Metabolic disease 113,023 (27.87) 122,305 (26.93) 131,169 (25.47) 92,875 (14.25) 80,604 (10.90)
Diabetes medication proﬁle
No diabetes medications 90,855 (22.40) 100,083 (22.03) 111,704 (21.69) 156,804 (24.06) 184,470 (24.95)
OHA only 194,465 (47.95) 225,577 (49.66) 262,912 (51.05) 331,657 (50.89) 374,659 (50.67)
OHA and insulin 54,365 (13.40) 65,627 (14.45) 75,571 (14.67) 88,390 (13.56) 100,331 (13.57)
Insulin only 65,895 (16.25) 62,934 (13.86) 64,783 (12.58) 74,901 (11.49) 79,917 (10.81)
Data are n (%). OHA: oral hypoglycemic agents; POW: prisoner of war; SC, service-connected.
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Tseng and Associatesrisk-adjustment models, we ﬁrst included
only theyearvariableinthe model (model
1), followed by models with demographic
variables (model 2), followed by adding
the variable representing microvascular
diseases (model 3), and then adding the re-
maining independent variables (model 4),
which we deﬁned as a full risk-adjustment
model. To further evaluate the effect of di-
abetes severity, we removed the diabetes
medication variable from model 4 to
create model 5. In addition, we evaluated
model 4 only among individuals with
microvascular diseases (model 6). Results
from these models are presented in Table
3. Finally, we evaluated trends of amputa-
tion by the race/ethnicity categories. The
study was approved by the institutional
review boards at East Orange Veterans Af-
fairs Medical Center (VAMC) and Bedford
VAMC.
RESULTS—Our study population in-
creased from 405,580 in FY 2000 to
739,377 in FY 2004, an 82% increase.
As reported in Table 1, missing data were
minimal and did not change over time,
with the exception that missing race/
ethnicity data increased from 2.3 to 5.7%.
Overall, some patient factors changed
over time. The number of married indi-
vidualsincreasedfrom60to65%;theper-
centage of individuals receiving insulin
(alone or with oral agents) decreased
from 29.7% in FY 2000 to 24.9% in FY
2004. Most dramatically, the percentage
of individuals with metabolic diseases
decreased from 27.9% in FY 2000 to
10.9% in FY 2004.
Table 2 reports counts, ratios of types
of ILEAs, and age- and sex-standardized
rates of ILEAs. Compared with FY 2000,
the number of total (2,870 to 3,547), mi-
nor (1,862 to 2,299), and major amputa-
tions (1,008 to 1,247) all increased
by ~24%. The counts of above-knee
amputation were relatively unchanged,
although below-knee amputations in-
creased from 436 in FY 2000 to 675 in
FY 2004. When comparing the ratios of
types of amputations across the years, the
ratios of major/minor amputations
showed little change; however, the ratios
of above-knee/below-knee amputations
progressively decreased from 1.31 in FY
2000 to 0.85 in FY 2004.
Age- and sex-standardized ILEA rates
declined by 34% over the 5-year period,
from .7t o,5/1,000 patients. The rate
for minor amputations decreased 33%,
from 4.59/1,000 in FY 2000 to 3.06/
1,000 in FY 2004, and the rate for major
amputations reduced 36%, from 2.49 to
1.59/1,000. Among major amputations,
the rate for below-knee amputations de-
creased 19%, from 1.08 to 0.87/1,000,
and the rate for above-knee amputations
reduced 49%, from 1.41 to 0.72/1,000.
Rates decreased across all racial/ethnic
groups,with whitesshowing agreater de-
cline (234%) than African Americans
(225%) or Hispanics (215%).
Table3reportsresultsforevaluationof
ILEA trends based on logistic regression
models with and without adjustment for
risk factors. Results from the ﬁrst model
that contains only the “year” variable
showed that the ORs (95% CI) decreased,
along with the progression of years, when
allyearsafterFY2000werecomparedwith
FY 2000, from 0.94 (0.89–0.99) in FY
2001 to 0.68 (0.64–0.71) in FY 2004. Re-
sults from models 2 to 4, in that different
risk factors were entered into the models,
also show similar downward trends. In
model 4, where all selected risk factors
were included, ORs slightly decreased
from 0.97 (0.92–1.02) in FY 2000 to 0.78
(0.74–0.82) in FY 2004, a 22% reduction
in the 5-year period (P , 0.01). When the
results were rerun using year as a continu-
ous variable, the downward trend re-
mained signiﬁcant for model 1 (0.90
[0.895–0.91]) and model 4 (0.95 [0.94–
0.96]). Model 5 (model 4 minus diabetes
medicationvariable)andmodel6(model4
based on individuals with microvascular
conditions) showed similar downward
trends to the main analyses.
Onthebasisofmodel4,weevaluated
whether the rates of decline for African
Americans and Hispanics were compara-
ble with those in the white population by
adding an interaction term of continuous
scale of “year” and “race/ethnicity.” Re-
sults showed that these three groups
were not signiﬁcantly different from
each other (African American vs. white,
P = 0.91; Hispanic vs. white, P = 0.37,
data not shown).
CONCLUSIONS—The age- and sex-
standardized rates of initial lower extrem-
ity amputationsreduced from 7.08/1,000
veterans in FY 2000 to 4.65/1,000 veter-
ans in FY 2004 who used the VHA health
care system—a marked decrease of 34%.
Table 2—ILEA counts and rates*: FY 2000–2004
Variable
FY 2000 FY 2001 FY 2002 FY 2003 FY 2004 Five-year reduction
n Rate n Rate n Rate n Rate n Rate %
Denominator 405,580 454,221 514,970 651,752 739,377
ILEA 2,870 7.08 3,019 6.64 3,101 5.98 3,492 5.24 3547 4.65 234.30
Level of amputation
Minor amputation 1,862 4.59 1,946 4.28 2,000 3.86 2,261 3.42 2299 3.06 233.30
Major amputation 1,008 2.49 1,073 2.36 1,101 2.12 1,231 1.82 1247 1.59 236.10
BK 436 1.08 511 1.12 537 1.04 615 0.92 675 0.87 219.40
AK 572 1.41 562 1.23 564 1.09 616 0.9 572 0.72 248.90
Ratio of major/minor 0.54 0.55 0.55 0.54 0.54
Ratio of AK/BK 1.31 1.10 1.05 1.00 0.85
Race/ethnicity
White 2,116 7.01 2,237 6.61 2,272 5.86 2,620 5.18 2664 4.63 234.00
African American 614 8.38 624 7.76 655 7.47 661 6.63 672 6.3 224.80
Hispanic 79 6.04 92 6.28 91 5.49 100 5.59 91 5.16 214.60
Other 56 7.27 57 6.7 76 8.01 70 6.16 58 4.47 238.50
*RatesarestandardizedtotheageandsexdistributionofthepopulationinFY2000andpresentedasper1,000patientswithdiabetesandnoprioramputation,aliveas
of the beginning of the year. AK, above knee; BK, below knee.
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Amputation rates in the Veterans AdministrationA similar decrease was noted in major
(236%)andminor(233%)amputations.
Although the population with diabetes
increased dramatically, 82%, during the
5-year period,the absolutenumbers ofmi-
norandbelow-kneeamputationsincreased
only moderately, and the counts of above-
kneeamputationshadlittlechange.Amore
important ﬁnding was a signiﬁcant down-
ward trend for ILEAs, even after we ad-
justed for population characteristics and
risk factors of amputations. This indicates
that the observed downward trend cannot
be ascribed only to population differences
across years of comparisons.
Our evaluation of major amputations
found that the rates of above-knee ampu-
tations had much greater decrease
(249%) during the 5-year study period
than rates of below-knee amputations
(219%). Furthermore, the counts of
below-knee amputations gradually in-
creased and above-knee amputations
remained the same during the 5-year pe-
riod, resulting in gradually decreased
ratios ofabove-knee/below-knee amputa-
tions from 1.31 in FY 2000 to 0.85 in FY
2004. Therefore, the decrease in the rate
of major amputations can be attributed
more to the decrease in above-knee than
in below-knee amputations.
The risk-adjusted models show a de-
crease of the magnitude of the contrast
between years of comparisons. For exam-
ple, for the contrast between the last and
ﬁrstyears,theOR(95%CI)changedfrom
0.68(0.64–0.71)withoutriskadjustment
(model 1) to 0.72 (0.68–0.75) with ad-
justment for demographic factors (model
2), and to 0.78 (0.74–0.82) with risk ad-
justment for all independent variables
(model 4, full risk-adjustment). In other
words, the risk reduction in the 5-year
period was 22% (model 4) rather than
32%(model1)whendifferencesinselected
important risk factors of ILEA across years
of comparison were considered. This
shrinkage of the contrast between years of
comparisons supports the importance of
adjusting for important risk factors in as-
sessing the trend of ILEA in patients with
diabetes.These resultsand thecomparison
of the absolute numbers of amputations
and the populations at risk together give
evidence for the presence of a “denomina-
tor effect.”
OurdatashowthatAfricanAmericans,
Hispanics, and whites all experienced sim-
ilar downward trends. When adjustments
are not made for potential confounders,
whites show a higher decrease rate
(234%), followed by African Americans
(225%) and Hispanics (215%). When
risk-adjusted, the rates of decrease in the
latter two groups were not different from
whites. We note that African Americans
continued, through the years of compari-
sons (2000–2004), to have the highest
rates.TherateforHispanics,althoughlower
than whites in years 2000–2003, became
higher than whites in 2004. These results
must be viewed with caution because our
databases do not contain variables, such as
education,income,smoking,andhealthbe-
haviors, which are essential for understand-
ing racial differences. In addition, there
were small numbers of Hispanic (as well as
the other non-white, non-black, and non-
Hispanic racial groups) who incurred am-
putations. Continuing evaluation of the
annual trends of amputations by patients’
racial/ethnic groups in future studies will
help improve our understanding of
racial/ethnic differences in ILEA rates.
Our ﬁnding of a 34% decrease in
initial total amputations was of compara-
ble magnitude to a 37% decrease in the
age-adjusted total amputation rates from
1998 to 2006 based on national estimates
o ft h ep r e v a l e n c eo fd i a b e t e s( 5 )a n da
26%decreaseintheage-andsex-adjusted
total amputation rates from 1992 to 2001
in Medicare beneﬁciaries with diabetes
(4). On the other hand, a recent study
fromtheU.K.(19)reportednosigniﬁcant
decrease in the rates of total, major, and
minoramputationsinindividualswithdi-
abetes (27.5 to 25.0/10,000) from 2004
to 2008; however, methodological differ-
encespreventdirectcomparisons.Incon-
trast to our study, these other studies did
not adjust for denominator effects and
did include repeat amputations. How-
ever, our ﬁnding of a 36% decline in ini-
tial major amputations over a 5-year
period is consistent with ﬁndings of a
48.8% decrease (94.4 to 48.3/10,000) in
the incidence of the ﬁrst major amputa-
tionwithina10-yearperiod(1997–2007)
from a national registry of Finnish indi-
viduals with diabetes (20).
In the late 1990s, the VHA imple-
mented a national program of foot risk
screeningandreferral,conductedlargelyin
primary care (21). As determined from
medical record reviews, 95% of veterans
had a visual examination, 84% had palpa-
tion of pulses, and 78% had undergone a
sensory examination by 1998. In addition,
~83% of patients had a monoﬁlament ex-
amination, and 85% of individuals with
risk factors were referred to foot specialists
in 2004 (13). We are unable to ascer-
tain whether veterans at higher risk for
lower extremity complications received
subsequent preventive foot care, such as
Table 3—Risk of ILEAs for the years of comparison (FY 2000–FY 2004): results from logistic regression models
Model FY 2000
FY 2001* FY 2002* FY 2003* FY 2004* Year†
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Model 1 (no risk
adjustment) Ref 0.94 (0.89–0.99) 0.85 (0.81–0.89) 0.76 (0.72–0.79) 0.68 (0.64–0.71) 0.90 (0.90–0.91)
Model 2 (only demographics) Ref 0.95 (0.90–1.00) 0.86 (0.82–0.91) 0.79 (0.75–0.83) 0.72 (0.68–0.75) 0.92 (0.91–0.93)
Model 3 (demographics +
microvascular disease) Ref 0.95 (0.90–1.00) 0.86 (0.81–0.90) 0.80 (0.76–0.84) 0.73 (0.70–0.77) 0.92 (0.91–0.93)
Model 4 (full risk-adjustment
model) Ref 0.97 (0.92–1.02) 0.88 (0.84–0.93) 0.85 (0.81–0.90) 0.78 (0.74–0.82) 0.95 (0.94–0.96)
Model 5 (model 4 without
diabetes medications) Ref 0.96 (0.91–1.01) 0.87 (0.83–0.92) 0.84 (0.80–0.89) 0.78 (0.74–0.82) 0.94 (0.93–0.95)
Model 6 (model 4 subselected
for patients with
microvascular disease) Ref 0.97 (0.92–1.02) 0.88 (0.84–0.93) 0.84 (0.80–0.89) 0.77 (0.73–0.81) 0.94 (0.93–0.95)
*Categoric measure. †Continuous measure.
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shoes, in the VHA or in the private sector.
Nonetheless, our ﬁndings suggest that im-
plementationofauniversalprogramoffoot
screening, tracked through performance
measures, may have contributed to a de-
crease in LEAs.
This study has several strengths. Our
ﬁndingsextendpriorstudiesbyaddressing
thedenominatoreffectthroughriskadjust-
ment of selected important risk factors
of LEA. We used individual-level data to
ascertain risk factors and other population
variables and included them in statistical
models for risk adjustment to minimize
possiblebiasesresultingfromdifferencesin
these factors. The individual-level data also
allowed us to determine the maximal am-
putationlevel(majorvs.minor)perepisode
when a patient underwent multiple ampu-
tations and hence allowed for accurate
estimates of total and type-speciﬁc ampu-
tations. The availability of longitudinal
data allowed us to distinguish initial
from repeat amputations. Furthermore,
the simultaneous evaluation of trends in
major and minor amputation rates pro-
vided important additional information
beyond total amputation rates alone.
We also note several limitations.
There is undercoding of key risk factors
for LEAs, such as insensate foot (neurop-
athy) and identiﬁcation of chronic kidney
disease (23). Mental health functioning
may be a risk factor for amputation (24)
but cannot be ascertained from adminis-
trative databases. In addition, because
mostveteransareduallyenrolledinMedi-
care (;75% in each year), the results
cannot be ascribed completely to care
provided within the VHA system. How-
ever, these are limitations common to ana-
lyses of administrative data (4,5,19,20).
In conclusion, downward 5-year
trends in initial amputation rates among
veterans with diabetes were observed for
all types of LEA and among all racial
groups,evenafteradjustmentforpossible
differences in risk of the patient popula-
tion. Our study demonstrates the value of
using multiple sources of individual-level
data to facilitate 1) the derivation of risk
f a c t o r so fo u t c o m e sa n d2) the evaluation
of possible factors contributing to the de-
nominator effects. Such information can
inform public health efforts (Healthy Peo-
ple 2020) to understand trends inamputa-
tion rates over the next decade (25).
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